Oxford Biomedica plc
Overview
Oxford Biomedica plc is a leading gene and cell therapy group focusing on the development and commercialization of novel gene-based therapies. With expertise in viral vector bioprocessing, the company partners with pharmaceutical and biotechnology companies to bring experimental treatments to market.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Oxford Biomedica plc in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.